Thursday, 13th of October 2016 |
The American Journal of Tropical Medicine and Hygienewww.ajtmh.org
1. Published online July 18, 2016 , doi: 10.4269/ajtmh.15-0923 Am J Trop Med Hyg 2016 vol. 95 no. 3 680-682
Decline in Child Hospitalization and Mortality After the Introduction of the 7-Valent Pneumococcal Conjugative Vaccine in Rwanda
1. Janvier Rurangwa1 and
2. Nadine Rujeni2,*
+ Author Affiliations
1. 1Department of Biology, College of Science and Technology, University of Rwanda, Kigali, Rwanda. 2. 2Department of Biomedical Laboratory Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.+ Author Notes
Authors addresses: Janvier Rurangwa, Department of Biology, College of Science and Technology, University of Rwanda, Kigali, Rwanda, E-mail: jr.herve002@gmail.com. Nadine Rujeni, Department of Biomedical laboratory Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda, E-mail: nrujeni@gmail.com.
1. ↵* Address correspondence to Nadine Rujeni, Department of Biomedical laboratory Sciences, College of Medicine and Health Sciences, University of Rwanda, Avenue de larmee, P.O. Box 3286, Kigali, Rwanda. E-mail: nrujeni@gmail.com
Abstract below; full text is available to journal subscribers.
Pneumonia is a public health problem in the tropics, and the 7-valent pneumococcal conjugative vaccine (PCV-7) has been introduced in an effort to prevent the disease and therefore reduce childhood mortality. In Rwanda, PCV-7 was introduced in 2009, and we aimed to determine its impact on the rate of child hospitalization/mortality due to pneumonia. A retrospective survey was conducted on hospitalization rates and pediatric deaths between two periods, that is, before the introduction of PCV-7 (2007–2009) and after the introduction of PCV-7 (2010–2013) in Kabutare District Hospital. There was a 53% reduction in hospitalization, with a significant decline in in-hospital deaths between the two periods. There was also a significant correlation between vaccination coverage and decline in hospitalization rates between 2009 and 2013. We conclude that PCV-7 vaccine is associated with significant reduction in the rate of child hospitalization and mortality but more mechanistic studies are warranted to determine the immunological impact, especially in the context of coinfections and malnutrition.
Footnotes
Financial support: The Rwanda Educational Board provided a scholarship to Janvier Rurangwa.
Received December 25, 2015.
Accepted May 19, 2016.
© The American Society of Tropical Medicine and Hygiene
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40944104 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |